Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Family Medicine
Disease Category: Diabetes Mellitus, Type 2
Location: United States, AR
Are you a diabetic with cardiovascular disease that has recently been hospitalized for a coronary event?
The purpose of this clinical research study is to evaluate the effectiveness of an investigational drug in preventing cardiovascular, heart and blood vessel events by lowering the blood sugar in subjects with Type II Diabetes.
Patient Inclusion Criteria:
- Experienced a coronary event at least 5 days and no more than 12 weeks ago
- History of type 2 diabetes
Patient Exclusion Criteria:
- Under 30 years of age
- Type 1 diabetes mellitus
- Other GLP-1 receptor agonists or DPP-IV inhibitors (e.g., exenatide, liraglutide, vildagliptin, sitagliptin)
Paul Koros, RN, Site Manager
NEA Baptist Clinic - Clinical Research Center
416 E. Washington, Suite C
Jonesboro, AR 72401
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these